Peter A van Veelen (Peter van Veelen)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 36

Top Topics

Acute Myeloid Leukemia

Mass Spectrometry

Top Venues

Nature communications

Journal of medicinal chemistry

Journal of immunology (Baltimore, Md. : 1950)

This page only lists publications with an associated author ORCID identifier.

Publications

Kyra J Fuchs, Marian van de Meent, M Willy Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Joan Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens. Blood 143 (18) (2024)
Daniel Salas-Lloret, Néstor García-Rodríguez, Emily Soto-Hidalgo, Lourdes González-Vinceiro, Carmen Espejo-Serrano, Lisanne Giebel, María Luisa Mateos-Martín, Arnoud H de Ru, Peter A van Veelen, Pablo Huertas, Alfred C O Vertegaal, Román González-Prieto
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. Nature communications 15 (1) (2024)
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell. Journal of medicinal chemistry 67 (10) (2024)
Daniel Salas-Lloret, Néstor García-Rodríguez, Emily Soto-Hidalgo, Lourdes González-Vinceiro, Carmen Espejo-Serrano, Lisanne Giebel, María Luisa Mateos-Martín, Arnoud H de Ru, Peter A van Veelen, Pablo Huertas, Alfred C O Vertegaal, Román González-Prieto
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. Nature communications 15 (1) (2024)
Maaike J M de Jong, Frank H Schaftenaar, Marie A C Depuydt, Fernando Lozano Vigario, George M C Janssen, Judith A H M Peeters, Lauren Goncalves, Anouk Wezel, Harm J Smeets, Johan Kuiper, Ilze Bot, Peter A van Veelen, Bram Slütter
Virus-Associated CD8 + T-Cells Are Not Activated Through Antigen-Mediated Interaction Inside Atherosclerotic Lesions. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Isabella Senini, Sara Tengattini, Francesca Rinaldi, Gabriella Massolini, Christoph Gstöttner, Dietmar Reusch, Marcello Donini, Carla Marusic, Peter A van Veelen, Elena Domínguez-Vega, Dana L E Vergoossen, Caterina Temporini, Simone Nicolardi
Direct glycosylation analysis of intact monoclonal antibodies combining ESI MS of glycoforms and MALDI-in source decay MS of glycan fragments. Communications chemistry 7 (1) (2024)
Daniel Salas-Lloret, Néstor García-Rodríguez, Emily Soto-Hidalgo, Lourdes González-Vinceiro, Carmen Espejo-Serrano, Lisanne Giebel, María Luisa Mateos-Martín, Arnoud H de Ru, Peter A van Veelen, Pablo Huertas, Alfred C O Vertegaal, Román González-Prieto
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. Nature communications 15 (1) (2024)
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell. Journal of medicinal chemistry 67 (10) (2024)
Maaike J M de Jong, Frank H Schaftenaar, Marie A C Depuydt, Fernando Lozano Vigario, George M C Janssen, Judith A H M Peeters, Lauren Goncalves, Anouk Wezel, Harm J Smeets, Johan Kuiper, Ilze Bot, Peter A van Veelen, Bram Slütter
Virus-Associated CD8 + T-Cells Are Not Activated Through Antigen-Mediated Interaction Inside Atherosclerotic Lesions. Arteriosclerosis, thrombosis, and vascular biology 44 (6) (2024)
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell. Journal of medicinal chemistry 67 (10) (2024)
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell. Journal of medicinal chemistry 67 (10) (2024)
Kyra J Fuchs, Marian van de Meent, Maria W Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic and hematopoietic HLA class I minor histocompatibility antigens. Blood (2024)
Daniel Salas-Lloret, Néstor García-Rodríguez, Emily Soto-Hidalgo, Lourdes González-Vinceiro, Carmen Espejo-Serrano, Lisanne Giebel, María Luisa Mateos-Martín, Arnoud H de Ru, Peter A van Veelen, Pablo Huertas, Alfred C O Vertegaal, Román González-Prieto
BRCA1/BARD1 ubiquitinates PCNA in unperturbed conditions to promote continuous DNA synthesis. Nature communications 15 (1) (2024)
Maaike J M de Jong, Frank H Schaftenaar, Marie A C Depuydt, Fernando Lozano Vigario, George M C Janssen, Judith A H M Peeters, Lauren Goncalves, Anouk Wezel, Harm J Smeets, Johan Kuiper, Ilze Bot, Peter A van Veelen, Bram Slütter
Virus-Associated CD8 + T-Cells Are Not Activated Through Antigen-Mediated Interaction Inside Atherosclerotic Lesions. Arteriosclerosis, thrombosis, and vascular biology (2024)
Yuqing Jia, Merve Oyken, Robbert Q Kim, Rayman T N Tjokrodirijo, Arnoud H de Ru, Antonius P A Janssen, Stephan M Hacker, Peter A van Veelen, Paul P Geurink, Aysegul Sapmaz
Development of Inhibitors, Probes, and PROTAC Provides a Complete Toolbox to Study PARK7 in the Living Cell. Journal of medicinal chemistry (2024)
Kyra J Fuchs, Marian van de Meent, M Willy Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Joan Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic, and hematopoietic HLA class I minor histocompatibility antigens. Blood 143 (18) (2024)
Kyra J Fuchs, Marian van de Meent, Maria W Honders, Indu Khatri, Michel G D Kester, Eva A S Koster, Georgia Koutsoumpli, Arnoud H de Ru, Cornelis A M van Bergen, Peter A van Veelen, Peter A C 't Hoen, Peter van Balen, Erik Ben van den Akker, Hendrik Veelken, Constantijn Jm Jm Halkes, J H Frederik Falkenburg, Marieke Griffioen
Expanding the repertoire reveals recurrent, cryptic and hematopoietic HLA class I minor histocompatibility antigens. Blood (2024)
Max S Kloet, Rishov Mukhopadhyay, Rukmini Mukherjee, Mohit Misra, Minwoo Jeong, Cami M P Talavera Ormeño, Angeliki Moutsiopoulou, Rayman T N Tjokrodirijo, Peter A van Veelen, Donghyuk Shin, Ivan Đikić, Aysegul Sapmaz, Robbert Q Kim, Gerbrand J van der Heden van Noort
Covalent Probes To Capture Legionella pneumophila Dup Effector Enzymes. Journal of the American Chemical Society (2024)
Eline C Brombacher, Thiago Andrade Patente, Alwin J van der Ham, Tijmen J A Moll, Frank Otto, Fenne W M Verheijen, Esther A Zaal, Arnoud H de Ru, Rayman T N Tjokrodirijo, Celia R Berkers, Peter A van Veelen, Bruno Guigas, Bart Everts
AMPK activation induces RALDH+ tolerogenic dendritic cells by rewiring glucose and lipid metabolism. The Journal of cell biology 223 (10) (2024)
Daniel Salas-Lloret, Nicolette S Jansen, Easa Nagamalleswari, Coen van der Meulen, Ekaterina Gracheva, Arnoud H de Ru, H Anne Marie Otte, Peter A van Veelen, Andrea Pichler, Joachim Goedhart, Alfred C O Vertegaal, Román González-Prieto
SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome. Science advances 9 (31) (2023)
Leoni Abendstein, Douwe J Dijkstra, Rayman T N Tjokrodirijo, Peter A van Veelen, Leendert Adrianus Trouw, Paul J Hensbergen, Thomas H Sharp
Complement is activated by elevated IgG3 hexameric platforms and deposits C4b onto distinct antibody domains. Nature communications 14 (1) (2023)
Chuannan Fan, Román González-Prieto, Thomas B Kuipers, Alfred C O Vertegaal, Peter A van Veelen, Hailiang Mei, Peter Ten Dijke
The lncRNA LETS1 promotes TGF-β-induced EMT and cancer cell migration by transcriptionally activating a TβR1-stabilizing mechanism. Science signaling 16 (790) (2023)
Bart Claushuis, Robert A Cordfunke, Arnoud H de Ru, Annemarie Otte, Hans C van Leeuwen, Oleg I Klychnikov, Peter A van Veelen, Jeroen Corver, Jan W Drijfhout, Paul J Hensbergen
In-Depth Specificity Profiling of Endopeptidases Using Dedicated Mix-and-Split Synthetic Peptide Libraries and Mass Spectrometry. Analytical chemistry (2023)
Bart Claushuis, Arnoud H de Ru, Sarah A Rotman, Peter A van Veelen, Lisa F Dawson, Brendan W Wren, Jeroen Corver, Wiep Klaas Smits, Paul J Hensbergen
Revised Model for the Type A Glycan Biosynthetic Pathway in Clostridioides difficile Strain 630Δ erm Based on Quantitative Proteomics of cd0241 - cd0244 Mutant Strains. ACS infectious diseases (2023)
Jin Gan, Jelle de Vries, Jimmy J L L Akkermans, Yassene Mohammed, Rayman T N Tjokrodirijo, Arnoud H de Ru, Robbert Q Kim, David A Vargas, Vito Pol, Rudi Fasan, Peter A van Veelen, Jacques Neefjes, Hans van Dam, Huib Ovaa, Aysegul Sapmaz, Paul P Geurink
Cellular Validation of a Chemically Improved Inhibitor Identifies Monoubiquitination on OTUB2. ACS chemical biology (2023)
Jitske van den Bulk, Elizabeth M E Verdegaal, Manon van der Ploeg, Marten Visser, Joana B Nunes, Arnoud H de Ru, Rayman T N Tjokrodirijo, Marieke E Ijsselsteijn, Natasja I Janssen, Ruud van der Breggen, Linda de Bruin, Pita de Kok, George M C Janssen, Dina Ruano, Ellen H W Kapiteijn, Peter A van Veelen, Noel F C C de Miranda, Sjoerd H Van der Burg
Neoantigen targetability in progressive advanced melanoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tom J Harryvan, Marten Visser, Linda de Bruin, Léonie Plug, Lisa Griffioen, Arend Mulder, Peter A van Veelen, Gerbrand J van der Heden van Noort, Marlieke Lm Jongsma, Miranda H Meeuwsen, Emmanuel Jhj Wiertz, Saskia J A M Santegoets, James Ch Hardwick, Thorbald van Hall, Jacques Neefjes, Sjoerd H Van der Burg, Lukas J A C Hawinkels, Elizabeth M E Verdegaal
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. Journal for immunotherapy of cancer 10 (3) (2022)
Paula Ruibal, Kees L M C Franken, Krista E van Meijgaarden, Marjolein van Wolfswinkel, Ian Derksen, Ferenc A Scheeren, George M C Janssen, Peter A van Veelen, Charlotte Sarfas, Andrew D White, Sally A Sharpe, Fabrizio Palmieri, Linda Petrone, Delia Goletti, Thomas Abeel, Tom H M Ottenhoff, Simone A Joosten
Identification of HLA-E Binding Mycobacterium tuberculosis -Derived Epitopes through Improved Prediction Models. Journal of immunology (Baltimore, Md. : 1950) 209 (8) (2022)
Miranda H Meeuwsen, Anne K Wouters, Renate S Hagedoorn, Michel G D Kester, Dennis F G Remst, Dirk M van der Steen, Arnoud de Ru, Peter A van Veelen, Jamie Rossjohn, Stephanie Gras, J H Frederik Falkenburg, Mirjam H M Heemskerk
Cutting Edge: Unconventional CD8 + T Cell Recognition of a Naturally Occurring HLA-A*02:01-Restricted 20mer Epitope. Journal of immunology (Baltimore, Md. : 1950) 208 (8) (2022)
Rosa A van Amerongen, Renate S Hagedoorn, Dennis F G Remst, Danique C Assendelft, Dirk M van der Steen, Anne K Wouters, Marian van de Meent, Michel G D Kester, Arnoud H de Ru, Marieke Griffioen, Peter A van Veelen, J H Frederik Falkenburg, Mirjam H M Heemskerk
WT1-specific TCRs directed against newly identified peptides install antitumor reactivity against acute myeloid leukemia and ovarian carcinoma. Journal for immunotherapy of cancer 10 (6) (2022)
Mary Luz Uribe, José Martín-Nieto, Cristina Quereda, Marcos Rubio-Fernández, Jesús Cruces, George M C Janssen, Arnoud H de Ru, Peter A van Veelen, Paul J Hensbergen
Retinal Proteomics of a Mouse Model of Dystroglycanopathies Reveals Molecular Alterations in Photoreceptors. Journal of proteome research 20 (6) (2021)
Elma Mons, Robbert Q Kim, Bjorn R van Doodewaerd, Peter A van Veelen, Monique P C Mulder, Huib Ovaa
Exploring the Versatility of the Covalent Thiol-Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease. Journal of the American Chemical Society 143 (17) (2021)
Antonius A de Waard, Tamara Verkerk, Marlieke L M Jongsma, Kelly Hoefakker, Sunesh Sethumadhavan, Carolin Gerke, Sophie Bliss, Xiangrui Kong, George M C Janssen, Arnoud H de Ru, Frans H J Claas, Arend Mulder, Robert Tampé, Peter A van Veelen, Anne Halenius, Robbert M Spaapen
PAKC: A novel panel of HLA class I antigen presentation machinery knockout cells from the same genetic origin. European journal of immunology 51 (3) (2021)
Steffen Lippold, Arnoud H de Ru, Jan Nouta, Peter A van Veelen, Magnus Palmblad, Dana L E Vergoossen, Noortje de Haan
Semiautomated glycoproteomics data analysis workflow for maximized glycopeptide identification and reliable quantification. Beilstein journal of organic chemistry 16 (2020)
Peter van Balen, Michel G D Kester, Wendy de Klerk, Pietro Crivello, Esteban Arrieta-Bolaños, Arnoud H de Ru, Inge Jedema, Yassene Mohammed, Mirjam H M Heemskerk, Katharina Fleischhauer, Peter A van Veelen, J H Frederik Falkenburg
Immunopeptidome Analysis of HLA-DPB1 Allelic Variants Reveals New Functional Hierarchies. Journal of immunology (Baltimore, Md. : 1950) 204 (12) (2020)
Raymond Kooij, Sijia Liu, Aysegul Sapmaz, Bo-Tao Xin, George M C Janssen, Peter A van Veelen, Huib Ovaa, Peter Ten Dijke, Paul P Geurink
Small-Molecule Activity-Based Probe for Monitoring Ubiquitin C-Terminal Hydrolase L1 (UCHL1) Activity in Live Cells and Zebrafish Embryos. Journal of the American Chemical Society 142 (39) (2020)